公开(公告)号：WO1992003202A2

公开(公告)日：1992-03-05

申请号：PCT/US1991005956

申请日：1991-08-20

Applicant: ABBOTT LABORATORIES

Inventor： ABBOTT LABORATORIES ,  KRUGER, Robert, J. ,  FREDERICK, Warren, P. ,  HELGREN, R., Hayes ,  LARKIN, Mark, E. ,  MAYORAL, Joaquin ,  SCHMOLESKY, Brad, A. ,  SICZEK, Roman, W. ,  TIMMONS, Kenneth, J.

IPC: B01D0

CPC classification number: B01D63/106 ,  A61M1/1643 ,  A61M1/1662 ,  A61M1/28 ,  A61M1/281 ,  A61M1/284 ,  A61M1/288 ,  A61M2205/3613 ,  B01D61/022 ,  B01D63/103 ,  B01D63/12 ,  B01D2311/08 ,  B01D2313/086 ,  B01D2313/143 ,  B01D2313/24 ,  C02F1/441 ,  B01D2311/14 ,  B01D2311/165

Abstract: Medical drug formulation and delivery system includes a reverse osmosis device for purifying water from a source comprising a housing having an inlet for passage of water from the source, a first outlet for passage of purified water from the housing and a second outlet for passage of waste water remaining after purification. A first reverse osmosis multilayer assembly is disposed within the housing in fluid communication with the inlet for purification of at least a first portion of the water from the source. Water treatment chemicals can be positioned in a core about which the first reserve osmosis multilayer assembly is wound. The treatment chemicals are in fluid communication with the first reverse osmosis multilayer assembly to receive the first purified portion of water and for removal of at least chemical contaminants therefrom. A second reverse osmosis multilayer assembly is also wound on the core and is in fluid communication with the water treatment chemicals to receive the chemically purified water for purification of at least a second portion thereof. The second reverse osmosis multilayer assembly is in fluid communication with the first outlet so as to permit passage of the second portion of purified water therethrough. In one preferred embodiment, the first and second reverse osmosis assemblies are formed integrally in a side by side configuration. In an alternative embodiment, they are rolled about the core in an interleaf configuration. A method of forming a reverse osmosis device, a peritoneal dialysis treatment system and alternative treatment systems incorporating such a device as well as corresponding methods of treatment are also disclosed.

Abstract translation: 药物制剂和递送系统包括用于净化来自源的水的反渗透装置，包括具有用于从源通过水的入口的壳体，用于使净化水从壳体通过的第一出口和用于通过废物的第二出口 净化后剩余水。 第一反渗透多层组件设置在壳体内，与入口流体连通，用于从源净化至少第一部分水。 水处理化学品可以位于卷绕第一储备渗透多层组件的核心中。 处理化学品与第一反渗透多层组件流体连通以接收第一纯化部分的水并且至少从其中去除化学污染物。 第二反渗透多层组件也缠绕在芯上并且与水处理化学品流体连通以接收用于纯化其至少第二部分的化学净化水。 第二反渗透多层组件与第一出口流体连通，以允许第二部分净化水通过其中。 在一个优选实施例中，第一和第二反渗透组件以并排构造一体地形成。 在替代实施例中，它们以插页配置围绕核心滚动。 还公开了形成反渗透装置的方法，腹膜透析治疗系统以及包含这种装置的替代治疗系统以及相应的治疗方法。